UniDoc Completes Purchase of AGNES Connect(R) Software from AMD Telemedicine
UniDoc Health Corp (OTCQB:UDOCF) has completed the acquisition of AGNES Connect software from AMD Telemedicine, as announced on March 28, 2025. The transaction, valued at US$175,000 plus a revenue share agreement, includes the acquisition of AMD Telemedicine's brand name, goodwill, software platform, intellectual property, and existing customer subscriptions.
The AGNES Connect software serves as the foundation for UniDoc's NEIL Connect software platform. CEO Antonio Baldassarre highlighted that AGNES Connect has an established national and international customer network and represents an opportunity for generating sustainable revenue through its existing commercial operations.
UniDoc Health Corp (OTCQB:UDOCF) ha completato l'acquisizione del software AGNES Connect da AMD Telemedicine, come annunciato il 28 marzo 2025. La transazione, del valore di 175.000 dollari USA più un accordo di condivisione dei ricavi, include l'acquisizione del marchio AMD Telemedicine, del goodwill, della piattaforma software, della proprietà intellettuale e degli abbonamenti dei clienti esistenti.
Il software AGNES Connect funge da base per la piattaforma software NEIL Connect di UniDoc. Il CEO Antonio Baldassarre ha sottolineato che AGNES Connect ha una rete di clienti consolidata a livello nazionale e internazionale e rappresenta un'opportunità per generare ricavi sostenibili attraverso le sue operazioni commerciali esistenti.
UniDoc Health Corp (OTCQB:UDOCF) ha completado la adquisición del software AGNES Connect de AMD Telemedicine, como se anunció el 28 de marzo de 2025. La transacción, valorada en 175,000 dólares estadounidenses más un acuerdo de participación en los ingresos, incluye la adquisición del nombre de marca de AMD Telemedicine, el goodwill, la plataforma de software, la propiedad intelectual y las suscripciones de clientes existentes.
El software AGNES Connect sirve como la base para la plataforma de software NEIL Connect de UniDoc. El CEO Antonio Baldassarre destacó que AGNES Connect tiene una red de clientes establecida a nivel nacional e internacional y representa una oportunidad para generar ingresos sostenibles a través de sus operaciones comerciales existentes.
UniDoc Health Corp (OTCQB:UDOCF)는 2025년 3월 28일 발표된 대로 AMD Telemedicine로부터 AGNES Connect 소프트웨어를 인수 완료했습니다. 이 거래는 175,000달러의 가치와 수익 공유 계약을 포함하며, AMD Telemedicine의 브랜드명, 영업권, 소프트웨어 플랫폼, 지적 재산권 및 기존 고객 구독을 포함합니다.
AGNES Connect 소프트웨어는 UniDoc의 NEIL Connect 소프트웨어 플랫폼의 기초 역할을 합니다. CEO 안토니오 발다사레는 AGNES Connect가 국내외에 확립된 고객 네트워크를 가지고 있으며, 기존 상업 운영을 통해 지속 가능한 수익을 창출할 수 있는 기회를 나타낸다고 강조했습니다.
UniDoc Health Corp (OTCQB:UDOCF) a finalisé l'acquisition du logiciel AGNES Connect auprès d'AMD Telemedicine, comme annoncé le 28 mars 2025. La transaction, d'une valeur de 175 000 dollars américains plus un accord de partage des revenus, comprend l'acquisition de la marque AMD Telemedicine, du goodwill, de la plateforme logicielle, de la propriété intellectuelle et des abonnements clients existants.
Le logiciel AGNES Connect sert de base à la plateforme logicielle NEIL Connect de UniDoc. Le PDG Antonio Baldassarre a souligné qu'AGNES Connect dispose d'un réseau de clients établi au niveau national et international et représente une opportunité de générer des revenus durables grâce à ses opérations commerciales existantes.
UniDoc Health Corp (OTCQB:UDOCF) hat die Übernahme der AGNES Connect Software von AMD Telemedicine abgeschlossen, wie am 28. März 2025 angekündigt. Die Transaktion, die mit 175.000 US-Dollar plus einer Umsatzbeteiligungsvereinbarung bewertet ist, umfasst den Erwerb des Markennamens von AMD Telemedicine, des Goodwills, der Softwareplattform, des geistigen Eigentums und der bestehenden Kundenabonnements.
Die AGNES Connect Software dient als Grundlage für die NEIL Connect Softwareplattform von UniDoc. CEO Antonio Baldassarre hob hervor, dass AGNES Connect ein etabliertes nationales und internationales Kundennetzwerk hat und eine Möglichkeit darstellt, nachhaltige Einnahmen durch die bestehenden kommerziellen Aktivitäten zu generieren.
- Acquisition brings established national and international customer base
- Potential for immediate revenue generation from existing subscriptions
- Strategic integration with NEIL Connect platform
- Full ownership and control of software development
- Cash outlay of US$175,000 plus ongoing revenue share obligations
VANCOUVER, BC / ACCESS Newswire / March 28, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company"), announces that, further to its news release dated March 19, 2025, it has closed the acquisition of the AGNES Connect software from AMD Telemedicine ("AMD").
"The AGNES Connect software forms the foundation of UniDoc's NEIL Connect software platform, and I am excited to complete this acquisition and bring the ownership and future development of this software in house. Additionally, AGNES Connect has been in commercial operation for several years and has established a national and international customer network. We look forward to supporting current subscribers and to build upon this existing customer base. For UniDoc, AGNES Connect represents an additional opportunity to generate sustainable revenue for the company," states CEO Antonio Baldassarre.
Pursuant to the terms of a definitive purchase agreement dated March 18, 2025, UniDoc has acquired from AMD several assets including the name "AMD Telemedicine" and related goodwill, the AGNES Connect software, and related intellectual property, customer subscriptions and accounts. As consideration, the Company paid AMD US
On Behalf of the Board of Directors,
~Antonio Baldassarre~
Antonio Baldassarre
CEO, President & Director
UniDoc Health Corp.
About UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF)
UniDoc is developing an eHealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician's office. eHealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company's belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our website at www.unidoctor.com and signup to receive the latest information with updates on our activities, events and progress.
For further information, please contact:
UniDoc Investor Relations
Tel: +1 778.383.6731
Email: info@unidoctor.com
Matt Chatterton, Director
Tel: +1 778.613.2082
Email: matt@unidoctor.com
Media Inquiries media@unidoctor.com
Forward-Looking Statements
Certain information contained herein constitutes "forward-looking information" under Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "anticipates", "anticipated" "expected" "intends" "will" or variations of such words and phrases or statements that certain actions, events or results "will" occur. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and they are from those expressed or implied by such forward-looking statements or forward-looking information subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different, including receipt of all necessary regulatory approvals. Although management of the Company have attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.
The CSE does not accept responsibility for the adequacy or accuracy of this release.
SOURCE: UniDoc Health Corp.
View the original press release on ACCESS Newswire
FAQ
What assets did UniDoc (UDOCF) acquire from AMD Telemedicine in March 2025?
How much did UniDoc (UDOCF) pay for the AGNES Connect software acquisition?
What is the strategic importance of AGNES Connect software for UniDoc (UDOCF)?
When did UniDoc (UDOCF) close the acquisition of AGNES Connect software?
